Donepezil does not improve chemotherapy-related cognitive impairment: Study Dr. Kamal Kant Kohli21 May 2024 9:15 PM ISTMany breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary. To test...
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint: Merck Ruchika Sharma11 May 2024 12:41 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA,...
Pfizer-Genmab gets full USFDA approval for Tivdak to treat recurrent or metastatic cervical cancer Ruchika Sharma30 April 2024 12:30 PM ISTNew York: Pfizer Inc. and Genmab A/S have announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations Ruchika Sharma28 April 2024 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
GSK application for expanded indication of Jemperli plus chemotherapy accepted by USFDA for priority review Ruchika Sharma25 April 2024 12:40 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for...
Merck gets Canadian nod for Keytruda in combo with fluoropyrimidine- and platinum-containing-chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma Ruchika Sharma23 April 2024 3:08 PM ISTKirkland: Merck, known as MSD outside the United States and Canada, has announced that Health Canada has granted approval of KEYTRUDA...
New Research Explores R-Cu's Potential in Oral Cancer Patients- Dr Hitesh R Singhavi Dr Hitesh R Singhavi22 April 2024 12:50 PM ISTResearchers from ACTREC, the research wing of Tata Hospital, are looking at a breakthrough in oral cancer treatment. This breakthrough can help make...
Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer: Study Dr. Kamal Kant Kohli21 April 2024 8:15 PM ISTFor patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of...
Lady Hardinge Medical College starts Radiation Therapy facility Kajal Rajput14 April 2024 1:30 PM ISTNew Delhi: Lady Hardinge Medical College (LHMC) marked a significant milestone with the inauguration of its Radiation Oncology Block on April 9,...
Submit analysis of clinical data of Asian, Indian Population: CDSCO Panel Tells AstraZeneca on Durvalumab Dr. Divya Colin13 April 2024 6:00 PM ISTNew Delhi: In response to the drug major AstraZeneca's proposal for the approval of additional indication of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL...
CDSCO Panel grants AstraZeneca's proposal for withdrawing specific Indications of Olaparib Tablets Dr. Divya Colin11 April 2024 6:00 PM ISTNew Delhi: Reviewing the Clinical evidence presented by drug major AstraZeneca, the Subject Expert Committee (SEC) functional under the Central Drug...
European Commission approves Merck Keytruda plus Chemotherapy for lung cancer Ruchika Sharma1 April 2024 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
